Welcome ACCORDANCE study from Intec!

Welcome Intec Pharma, currently conducting the Phase III ACCORDANCE study of the carbidopa/ levodopa “Accordion Pill.”

Moving Day has raised nearly $40 million and brought more than 173,000 participants together.